Individual Risk Assessment and Prognostication of Outcomes After Corneal Cross-Linking.

Corneal collagen cross-linking (CXL) is a treatment which arrests keratoconus (KC) progression, but its effectiveness differs radically among patients. Herein, we report preoperative diagnostic findings that reflect CXL outcomes and allow physicians to prognosticate treatment efficiency. In a medical centre, we retrospectively analysed pre- and postoperative data about 107 patients (112 eyes) treated with CXL from January 2018 to December 2022. Exclusion criteria were age below 16 years, a corneal thickness below 400 microns, severe dry eye, other corneal diseases/infections, re-CXL, pregnancy and missing follow-up examinations. All the subjects (79 males and 28 females) were followed for a minimum of 4 and a maximum of 40 months. The study dataset was comprised of 796 cases of clinical assessment, pachymetry, visiometry, refractometry and topography examinations. With these data, we modelled maximum anterior keratometry ( ) and curvature power of the flat and steep meridians of the corneal anterior surface ( and ). Two years after the invasion, corneal curvature coefficients decreased progressively. Then, they remained stable for four months and rose afterwards. In the most accurate , and models, the proportion of mean absolute error to the range of values was 1.72, 3.66 and 2.37%, respectively. Pronounced corneal thinning, low best-corrected visual acuity and high levels predict unfavourable outcomes. The high accuracy of the models advocates for a personalised approach to candidate selection for CXL.